Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

Multiply Labs, a robotics firm, and Retro Biosciences, which is developing therapies to address age-related diseases, signed an agreement valued at up to $85 million to automate Retro’s approach to ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Teradyne, Inc. (NASDAQ:TER) is one of the 10 Best Semiconductor Stocks to Buy Right Now. On August 21, it was announced that Multiply Labs developed a new robotic biomanufacturing cluster, which ...

By utilizing Multiply Labs' cell therapy robotic cluster and GenScript's GMP-grade CytoSinct 1000 cell isolation solution, capable of isolating up to 120X10^9 total cells within a single hour, this ...

Multiply Labs, a San Francisco-based robotics company developing advanced automated manufacturing systems for cell therapies, announced an expansion of its collaboration with Thermo Fisher Scientific.